Lotfi Abou-Elkacem

Title: Lotfi Abou-Elkacem: Innovator in Affibody Proteins

Introduction

Lotfi Abou-Elkacem is a notable inventor based in Houston, Texas. He has made significant contributions to the field of biotechnology, particularly in the development of affibody proteins. His work focuses on creating innovative solutions for medical imaging and therapeutic applications.

Latest Patents

Abou-Elkacem holds a patent for "Affibody proteins specific for B7-H3 (CD276)." This patent includes affibody polypeptides that specifically bind to B7-H3 with high affinity. The affibodies can be conjugated to contrast agents, such as microbubbles, for use in contrast-enhanced ultrasound imaging. This innovation has the potential to improve diagnostic imaging techniques.

Career Highlights

Lotfi Abou-Elkacem is affiliated with the University of Minnesota, where he conducts research and develops his inventions. His work has garnered attention for its potential applications in medical diagnostics and treatment. He has a strong focus on advancing the understanding of protein interactions in the context of disease.

Collaborations

Abou-Elkacem has collaborated with notable researchers, including Juergen Karl Willmann and Benjamin Joseph Hackel. These collaborations have contributed to the advancement of his research and the development of innovative technologies in the field.

Conclusion

Lotfi Abou-Elkacem is a prominent inventor whose work on affibody proteins is paving the way for advancements in medical imaging. His contributions to biotechnology are significant and continue to influence the field.